Literature DB >> 24751633

Approaches to growth faltering.

Brenda Poindexter1.   

Abstract

Postnatal growth failure remains a nearly universal complication of extreme prematurity. The incidence of postnatal growth failure is inversely related to gestational age. Unfortunately, by the time growth faltering is recognized, the nutrient deficits that have accumulated can be difficult, if not impossible, to recover. The perceived severity of illness in the first week can significantly impact decisions made related to early nutritional support. It is becoming increasingly clear that optimizing nutrient intake in the first few weeks of life is critical to reduce growth faltering. In order to promote growth and reduce growth faltering, a goal of 120 kcal/kg/day and 3.8 g/kg/day of protein should be supplied to very low birth weight infants by the end of the first week. A combined strategy of both parenteral and enteral nutrition is necessary to ensure that adequate protein and energy intake is delivered and that nutrient deficits are minimized. Finally, careful monitoring of growth--including both linear and head circumference growth--is necessary to achieve optimal outcomes.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24751633     DOI: 10.1159/000358471

Source DB:  PubMed          Journal:  World Rev Nutr Diet        ISSN: 0084-2230            Impact factor:   0.575


  2 in total

1.  Effect of early versus standard central line removal on growth of very low birthweight premature infants: a protocol for a non-inferiority randomised controlled trial.

Authors:  Justyna Romańska; Wojciech Margas; Renata Bokiniec; Paweł Krajewski; Joanna Seliga-Siwecka
Journal:  BMJ Open       Date:  2019-09-17       Impact factor: 2.692

2.  Adequacy of Parenteral Nutrition in Preterm Infants According to Current Recommendations: A Study in A Spanish Hospital.

Authors:  Ana María Sánchez-García; Ana Zaragoza-Martí; Ana Cristina Murcia-López; Andrés Navarro-Ruiz; Ana Noreña-Peña
Journal:  Int J Environ Res Public Health       Date:  2020-03-23       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.